Carpenter Technology Corporation
CRS
$607.03
+2.58%
Carpenter Technology Corporation is a leading manufacturer and supplier of specialty metals, including high-performance alloys and stainless steels, serving critical end markets such as aerospace and defense, medical, energy, and industrial machinery. The company is a key player in the metal fabrication industry, distinguished by its technical expertise in producing materials that meet stringent specifications for demanding applications. The current investor narrative is heavily focused on a robust cyclical recovery, particularly within the aerospace and defense sector, which is driving significant revenue growth and margin expansion, as evidenced by recent quarterly results and a dramatic surge in the stock price over the past year.…
CRS
Carpenter Technology Corporation
$607.03
Investment Opinion: Should I buy CRS Today?
Rating: Hold. The core thesis is that CRS is a high-quality company in a powerful upcycle, but its risk/reward is balanced after a 116% rally, as the current price largely reflects the positive narrative, leaving limited margin of safety.
Supporting Evidence: The Hold rating is anchored by four data points: 1) The stock trades at a significant premium with a 36.9x trailing P/E and 46.7x forward P/E, well above industrial peers. 2) Revenue growth is solid at 7.55% YoY, but the valuation demands this pace continue. 3) Profitability is strong with a net margin of 14.46% and expanding gross margin of 29.99%. 4) Analyst sentiment is positive but based on only two estimates, introducing coverage risk.
Risks & Conditions: The two biggest risks are a cyclical slowdown in aerospace and a valuation de-rating. This Hold would upgrade to a Buy if the stock experiences a meaningful pullback (e.g., below $450) that improves the risk/reward, or if forward earnings significantly surpass the $16.15 estimate. It would downgrade to Sell if quarterly revenue growth decelerates below 5% or if net margins contract below 12%, signaling cycle peak. The stock is currently overvalued relative to its sector and its own history, pricing in near-perfect execution.
Sign up to view all
CRS 12-Month Price Forecast
The outlook is balanced with a slight tilt toward caution. The fundamental story is compelling, driven by aerospace, but the stock's massive run and premium valuation have captured most of the near-term upside. The base case (55% probability) of consolidation and digestion is most likely. The stance would upgrade to bullish on a pullback that improves the valuation entry point or clear evidence of a prolonged cycle. It would turn bearish on any concrete sign of cyclical deceleration in order books or margins. The key is whether growth can outrun multiple compression over the next year.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Carpenter Technology Corporation's 12-month outlook, with a consensus price target around $789.14 and implied upside of +30.0% versus the current price.
Average Target
$789.14
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$486 - $789
Analyst target range
Analyst coverage for CRS is limited, with only two analysts providing estimates, which is typical for a mid-cap industrial name and can lead to higher volatility and less efficient price discovery. The consensus leans bullish, with recent institutional ratings from firms like JP Morgan and BTIG maintaining 'Overweight' and 'Buy' stances, respectively, and the average estimated EPS for the forward period is $16.15. The target price range implied by the revenue estimates is wide, spanning from approximately $3.996 billion to $4.156 billion, reflecting uncertainty around the sustainability of the current aerospace cycle and the company's ability to maintain its elevated margin structure.
Bulls vs Bears: CRS Investment Factors
The bull case, driven by explosive fundamental growth in the aerospace cycle and powerful technical momentum, currently holds stronger evidence, as reflected in the stock's 116% annual gain and robust quarterly margins. However, the bear case presents a formidable counter-argument centered on extreme valuation and cyclical risk. The single most important tension in the investment debate is whether the current aerospace-driven earnings growth can sustain long enough to justify the stock's premium valuation (36.9x trailing P/E) before the inevitable cyclical downturn or a de-rating occurs. The resolution of this tension will determine if CRS is a late-cycle winner or a prime candidate for a significant multiple contraction.
Bullish
- Explosive Revenue & Profit Growth: Recent quarterly revenue of $728.0 million represents a 7.55% YoY increase, accelerating from the $676.9 million reported a year ago. Net income surged to $105.3 million, yielding a robust net margin of 14.46%, demonstrating significant operating leverage from the aerospace cycle.
- Strong Aerospace & Defense Demand: The Aerospace and Defense segment is the primary driver, contributing $472.0 million in the latest quarter. This critical end-market's multi-year recovery provides a durable tailwind for revenue and high-margin sales.
- Exceptional Technical Momentum: The stock has gained 116.49% over the past year and 57.00% over the past three months, dramatically outperforming the S&P 500. It is trading near its 52-week high of $605.11, indicating sustained bullish conviction and strong price discovery.
- Healthy Balance Sheet & Cash Flow: The company maintains a strong current ratio of 3.65 and a manageable debt-to-equity of 0.39. It generated substantial TTM free cash flow of $316.7 million, providing internal funding for growth and resilience against downturns.
Bearish
- Extreme Valuation Premium: The trailing P/E of 36.9x and forward P/E of 46.7x represent a significant premium to typical Industrials sector averages (often in the low 20s). This high multiple leaves the stock vulnerable to compression if growth expectations falter.
- Cyclical Peak & Concentration Risk: The investment thesis is heavily reliant on the aerospace cycle, which is historically cyclical. The stock's P/E of 36.9x is near the top of its own historical range, suggesting the market is pricing in a near-perfect execution of the upcycle.
- High Volatility & Overextension: With a beta of 1.27, the stock is 27% more volatile than the market. Trading at ~98% of its 52-week high after a 116% annual gain, it is technically extended and susceptible to a sharp pullback on any negative news.
- Limited Analyst Coverage: Only two analysts provide estimates, leading to less efficient price discovery and potentially higher volatility. The wide revenue target range ($4.0B to $4.2B) reflects significant uncertainty about the sustainability of current performance.
CRS Technical Analysis
The stock is in a powerful, sustained uptrend, having gained 116.49% over the past year and trading at approximately 98% of its 52-week high of $605.11, indicating strong momentum but also potential overextension near its peak. Recent momentum has accelerated sharply, with the stock up 28.39% over the past month and 57.00% over the past three months, significantly outpacing the S&P 500's returns of -2.86% and 14.97% over the same periods, respectively. The stock exhibits high volatility with a beta of 1.27, meaning it is approximately 27% more volatile than the broader market, which is a critical consideration for risk management. Key technical support is anchored at the 52-week low of $228.00, while immediate resistance is at the 52-week high of $605.11; a decisive breakout above this level could signal a continuation of the bullish trend, whereas a failure could lead to a significant pullback given the stock's extended positioning.
Beta
1.27
1.27x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$228-$608
Price range past year
Annual Return
+120.1%
Cumulative gain past year
| Period | CRS Return | S&P 500 |
|---|---|---|
| 1m | +29.4% | -2.0% |
| 3m | +54.0% | +13.9% |
| 6m | +92.8% | +8.7% |
| 1y | +120.1% | +20.5% |
| ytd | +79.4% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRS Fundamental Analysis
Revenue growth is robust, with the most recent quarterly revenue of $728.0 million representing a 7.55% year-over-year increase, and the multi-quarter trend shows a clear acceleration from the $676.9 million reported in the year-ago quarter. The Aerospace and Defense segment is the primary growth driver, contributing $472.0 million in the latest period, while the Energy and Medical markets added $50.8 million and $70.7 million, respectively. Profitability has improved dramatically, with net income reaching $105.3 million in the latest quarter, yielding a net margin of 14.46%, and gross margin expanding to 29.99% from 26.22% a year ago, indicating significant operating leverage. The company maintains a strong balance sheet with a healthy current ratio of 3.65 and a manageable debt-to-equity ratio of 0.39, while generating substantial free cash flow of $316.7 million (TTM), providing ample internal funding for growth and shareholder returns.
Quarterly Revenue
$728000000.0B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$316700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRS Overvalued?
Given the positive net income of $105.3 million, the primary valuation metric is the P/E ratio. The trailing P/E stands at 36.9x, while the forward P/E is 46.7x, indicating the market is pricing in expectations for near-term earnings growth. Compared to the broader Industrials sector, Carpenter's trailing P/E of 36.9x trades at a significant premium to typical industry averages (often in the low 20s), justified by its superior growth trajectory and margin profile. Historically, the stock's current trailing P/E of 36.9x is near the top of its own multi-year range, which has seen lows in the single digits during downturns and highs in the 30s during previous peaks, suggesting the market is pricing in optimistic expectations for the current cycle.
PE
36.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -66x~142x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CRS's primary financial risk is its valuation dependency on continued high growth. The forward P/E of 46.7x implies flawless execution; any deceleration in the 7.55% YoY revenue growth or compression from the 14.46% net margin would trigger severe multiple compression. While the balance sheet is strong (D/E of 0.39), the company faces operational concentration, with the Aerospace & Defense segment driving the majority of profits, making it vulnerable to a slowdown in commercial aviation or defense spending.
Market & Competitive Risks: The stock faces pronounced market risk from its premium valuation trading at a 36.9x trailing P/E versus sector norms. A shift in investor sentiment away from cyclical growth or a rise in interest rates could compress this premium rapidly. Its high beta of 1.27 means it will likely fall more than the market in a downturn. Competitively, while it holds a niche in specialty metals, pricing power could be challenged if raw material costs rise or if competitors increase capacity.
Worst-Case Scenario: The worst-case scenario involves a double-hit of cyclical downturn and valuation de-rating. A recession curtails aerospace demand, causing revenue growth to stall and margins to contract toward historical lows. Simultaneously, the P/E multiple re-rates from 36.9x down toward the industrial sector average of ~20x. This could realistically drive the stock back toward its 52-week low of $228.00, representing a downside of approximately -61% from the current price of ~$592. A more probable severe bear case might see a -35% to -40% drawdown to the $350-$385 range, aligning with prior support levels and a more moderate multiple compression.
FAQ
The key risks are: 1) Cyclical & Concentration Risk: Heavy reliance on the aerospace cycle; a downturn could swiftly reverse the 7.55% revenue growth. 2) Valuation Risk: The 36.9x P/E is vulnerable to compression if growth slows, potentially leading to a -35%+ drawdown. 3) Volatility Risk: A beta of 1.27 means the stock is 27% more volatile than the market, amplifying losses in downturns. 4) Coverage Risk: Limited analyst coverage (only 2) can lead to erratic price movements and less informed consensus. The cyclical valuation risk is currently the most severe.
The 12-month forecast presents three scenarios. The Bull Case (25% probability) targets $605-$650, assuming the cycle accelerates. The Base Case (55% probability) targets $520-$590, assuming steady execution and consolidation. The Bear Case (20% probability) targets $350-$450, assuming a cycle peak and de-rating. The Base Case is most likely, anchored by current analyst estimates and the expectation that the stock digests its massive gains. The key assumption is that aerospace demand remains stable, allowing CRS to maintain its elevated margins.
CRS is overvalued relative to its industrial sector peers but may be fairly valued if its superior growth persists. Its trailing P/E of 36.9x and forward P/E of 46.7x are at a significant premium to typical industrial averages in the low 20s. Historically, its own P/E is near the top of its range. This premium implies the market expects the current aerospace-driven earnings growth (7.55% revenue increase, 14.46% net margin) to continue unabated. Any stumble would likely cause a sharp de-rating, making the current valuation demanding.
CRS is a good buy only for investors comfortable with high risk and volatility, seeking cyclical growth. The stock has immense momentum, up 116% in a year, and strong fundamentals with a 14.46% net margin. However, at a 36.9x trailing P/E, it is expensive, leaving little margin for error. The biggest downside risk is a cyclical slowdown triggering a severe multiple contraction. It may be a good buy on a significant pullback for long-term holders, but at current levels, the risk/reward is balanced, warranting a 'Hold' stance for most.
CRS is more suitable for a medium-term, cyclical investment horizon (1-3 years) rather than a very long-term buy-and-hold or short-term trade. Its fortunes are tied to the current aerospace cycle, which has years to run but is not permanent. The high beta of 1.27 and lack of a meaningful dividend (yield 0.29%) make it poor for income or low-volatility portfolios. Investors should have a minimum horizon of 12-18 months to ride out inevitable volatility and capture the cyclical upswing, with a plan to reassess as cycle indicators evolve.